COMMUNIQUÉS West-GlobeNewswire

Translate Bio Announces Pricing of Public Offering of Common Stock
18/09/2019
LEXINGTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
IGM Biosciences Announces Pricing of Initial Public Offering
18/09/2019
MOUNTAIN VIEW, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the pricing of its initial public offering of 10,937,500 shares of its common stock at a price to the public [...]
NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vaccine V920 (rVSV∆G-ZEBOV-GP)
17/09/2019
AMES, Iowa, Sept. 17, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that the U.S. Food and Drug Administration (FDA) has accepted Merck’s Biologics License Application (BLA) and [...]
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2019
17/09/2019
Conférence téléphonique et webcast le mercredi 18 septembre à 14h30 (heure de Paris) Déroulement comme prévu de l’étude TRYbeCA1 de Phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas [...]
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019
17/09/2019
Conference call and webcast on Wednesday, September 18 at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancreatic cancer, progressing on plan Immune modulation collaboration entered into [...]
CymaBay Therapeutics Announces Departure of Chief Medical Officer
17/09/2019
NEWARK, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
RTI Surgical® Announces First Spine Surgery Using the HPS™ 2.0 Hybrid Performance System
17/09/2019
The HPS 2.0 system incorporates clinically proven technology to significantly reduce the risk of adjacent segment degeneration DEERFIELD, Ill., Sept. 17, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: [...]
Adamas Announces New Employment Inducement Grant
17/09/2019
EMERYVILLE, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted its new Chief Executive [...]
Equillium to Host Business Update Call on October 1, 2019
17/09/2019
LA JOLLA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, leveraging deep understanding of immunobiology to develop products to treat severe autoimmune [...]
BioDelivery Sciences Announces Participation in Upcoming Investor Conferences
17/09/2019
RALEIGH, N.C., Sept. 17, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares
17/09/2019
STAMFORD, Conn., Sept. 17, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17/09/2019
SANTA BARBARA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on September 12, 2019, the Compensation Committee of the Company’s Board of [...]
Xenon Announces Appointment of Shelley McCloskey as Senior Vice President, Human Resources
17/09/2019
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BURNABY, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, [...]
Maple Leaf Green World Inc. Signs A Letter Of Intent To Supply Hemp Seeds To A South East Asian CBD Producer
17/09/2019
CALGARY, Alberta, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) announces it has entered into a Letter of Intent ( LOI) , with a Singapore [...]
Optinose Announces Departure of Chief Commercial Officer
17/09/2019
Company reiterates guidance for XHANCE net revenues for 2019 to be in the range of $29 - $34 million YARDLEY, Pa., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients [...]
Translate Bio Announces Proposed Public Offering of Common Stock
17/09/2019
LEXINGTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Devonian annonce la prolongation de son placement privé
17/09/2019
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 17 sept. 2019 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSXV: GSD) annonce qu’elle a obtenu [...]
Theresa McConeghey Receives NADP Gabryl Award
17/09/2019
National Lifetime Achievement Award Honors Contributions to Dental Benefits Industry DALLAS, Sept. 17, 2019 (GLOBE NEWSWIRE) -- In recognition of her excellent, long-term volunteer service advancing the dental benefits [...]
Spineway : Adjournment of the Ordinary and Extraordinary General Shareholders’ Meeting to be held on 19 september 2019
17/09/2019
Adjournment of the Ordinary and Extraordinary General Shareholders’ Meeting to be held on 19 september 2019 Shareholders are hereby informed that, by decision dated on September 13, 2019, the Board of Directors has [...]

Pages